Regulation of pharmacology by hetero-oligomerization between A1 adenosine receptor and P2Y2 receptor

Biochemical and Biophysical Research Communications

Volumn 351, Issue 2, 2006, Pages 559-565

  Suzuki, Tokiko ^a   Namba, Kazunori ^a   Tsuga, Hirofumi ^a   Nakata, Hiroyasu ^a  

^a TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

Author keywords

Adenosine receptor; Adenylate cyclase; Calcium mobilization; Dimer; GPCR; HEK293T; Hetero oligomer; P2 receptor; Purinergic receptor

Indexed keywords

ADENOSINE A1 RECEPTOR; ADENOSINE A1 RECEPTOR AGONIST; ADENOSINE RECEPTOR; ADENYLATE CYCLASE; ADENYLATE CYCLASE INHIBITOR; G PROTEIN COUPLED RECEPTOR; HETERODIMER; PURINE P2 RECEPTOR; PURINE P2Y2 RECEPTOR; PURINE RECEPTOR; PURINERGIC RECEPTOR STIMULATING AGENT;

ARTICLE; CALCIUM CELL LEVEL; CALCIUM MOBILIZATION; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL LINE; CONTROLLED STUDY; EMBRYO; ENZYME INHIBITION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; OLIGOMERIZATION; PRIORITY JOURNAL; RECEPTOR BINDING;

ADENOSINE-5'-(N-ETHYLCARBOXAMIDE); ANIMALS; CALCIUM; CELL LINE; CELL MEMBRANE; CLONING, MOLECULAR; CYCLIC AMP; HUMANS; PROTEIN BINDING; RATS; RECEPTOR, ADENOSINE A1; RECEPTORS, PURINERGIC P2; URIDINE TRIPHOSPHATE; XANTHINES;

EID: 33750528947     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2006.10.075     Document Type: Article

References (19)

1. Angers S., Salahpour A., and Bouvier M. Dimerization: an emerging concept for G protein-coupled receptor ontogeny and function. Annu. Rev. Pharmacol. Toxicol. 42 (2002) 409-435
2. Prinster S.C., Hague C., and Hall R.A. Heterodimerization of G protein-coupled receptors: specificity and functional significance. Pharmacol. Rev. 57 (2005) 289-298
3. Milligan G. G-protein-coupled receptor heterodimers: pharmacology, function and relevance to drug discovery. Drug Discov. Today 11 (2006) 541-549
4. Nakata H., Yoshioka K., and Kamiya T. Purinergic-receptor oligomerization: implications for neural functions in the central nervous system. Neurotox. Res. 6 (2004) 291-297
5. Yoshioka K., Saitoh O., and Nakata H. Heteromeric association creates a P2Y-like adenosine receptor. Proc. Natl. Acad. Sci. USA 98 (2001) 7617-7622
6. Ralevic V., and Burnstock G. Receptors for purines and pyrimidines. Pharmacol. Rev. 50 (1998) 413-492
7. Burnstock G., and Williams M. P2 purinergic receptors: modulation of cell function and therapeutic potential. J. Pharmacol. Exp. Ther. 295 (2000) 862-869
8. Shaver S.R. P2Y receptors: biological advances and therapeutic opportunities. Curr. Opin. Drug Discov. Devel. 4 (2001) 665-670
9. Chen Y., Shukla A., Namiki S., Insel P.A., and Junger W.G. A putative osmoreceptor system that controls neutrophil function through the release of ATP, its conversion to adenosine, and activation of A2 adenosine and P2 receptors. J. Leukoc. Biol. 76 (2004) 245-253
10. - currents in normal and cystic fibrosis airway epithelial cells. J. Biol. Chem. 268 (1993) 24779-24784
11. 1 adenosine receptors in normal and cystic fibrosis human airway epithelial cells. Am. J. Physiol. 268 (1995) C1520-C1527
12. 2-purinoceptor-mediated activation of the mitogen-activated protein kinase cascade in transfected CHO cells. Br. J. Pharmacol. 124 (1998) 1491-1499
13. 1 MF-2 cells. Cell. Mol. Neurobiol. 23 (2003) 379-400
14. 2 nucleotide receptor interact with Src and regulate activities of Src, proline-rich tyrosine kinase 2, and growth factor receptors. J. Biol. Chem. 279 (2004) 8212-8218
15. 2 nucleotide receptor function: implications for proliferative and inflammatory pathways in astrocytes. Mol. Neurobiol. 31 (2005) 169-183
16. 2 receptor in mouse pineal gland tumor cells. J. Neurochem. 77 (2001) 1475-1485
17. B receptor heterodimerization. Neuron 27 (2000) 97-106
18. 2-adrenergic receptor. Proc. Natl. Acad. Sci. USA 101 (2004) 13672-13676
19. 1B-adrenergic receptors. J. Biol. Chem. 279 (2004) 15541-15549